AGF U.S. Market Neutral Anti-Beta Fund (BTAL)

Assets	$346.95M
Expense Ratio	1.40%
PE Ratio	17.82
Shares Out	25.70M
Dividend (ttm)	$0.36
Dividend Yield	2.81%
Ex-Dividend Date	Dec 30, 2025
Payout Frequency	Annual
Payout Ratio	51.01%

Volume	549,540
Open	12.69
Previous Close	12.65
Day's Range	12.66 - 12.82
52-Week Low	12.31
52-Week High	20.41
Beta	-0.57
Holdings	405
Inception Date	Sep 13, 2011

About BTAL

Fund Home Page

The AGF U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long/short alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is issued by AGF.

• Asset Class: Alternatives
• Category: Equity Market Neutral
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BTAL
• ETF Provider: AGF
• Index Tracked: Dow Jones U.S. Thematic Market Neutral Low Beta Index

Top 10 Holdings

109.60% of assets

Name	Symbol	Weight
Cash	n/a	104.96%
Murphy USA Inc.	MUSA	0.58%
Molina Healthcare, Inc.	MOH	0.53%
CF Industries Holdings, Inc.	CF	0.52%
UnitedHealth Group Incorporated	UNH	0.52%
VeriSign, Inc.	VRSN	0.51%
Virtu Financial, Inc.	VIRT	0.51%
Arrow Electronics, Inc.	ARW	0.50%
Watsco, Inc.	WSO	0.49%
F5, Inc.	FFIV	0.48%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.35788	Jan 2, 2026
Dec 30, 2024	$0.6449	Jan 2, 2025
Dec 27, 2023	$1.0409	Jan 2, 2024
Dec 28, 2022	$0.2132	Jan 3, 2023
Dec 27, 2019	$0.1958	Jan 3, 2020
Dec 27, 2018	$0.0858	Jan 3, 2019

Performance

BTAL had a total return of -34.73% in the past year, including dividends. Since the fund's inception, the average annual return has been -3.60%.